CNR1 and endothelial dysfunction: Importantly, the biotransformation approach aligns with our long-term goal of developing safe, fermentation-derived CB1-modulating agents for preventing endothelial dysfunction and enables robust evaluation of the vascular protective effects of G7P and D7P.